Journal
ANNALS OF PHARMACOTHERAPY
Volume 34, Issue 3, Pages 382-385Publisher
SAGE PUBLICATIONS INC
DOI: 10.1345/aph.19150
Keywords
levodopa; melanoma
Categories
Ask authors/readers for more resources
OBJECTIVE: To evaluate the use of levodopa therapy in patients with Parkinson's disease adn malignant melanoma. DATA SOURCES: A MEDLINE search (January 1966-September 1999) of English-language articles was conducted. Key search terms included levodopa, melanoma, and Parkinson's disease: 34 case reports were identified. DATA SYNTHESIS: Carbidopa/levodopa continues to be a mainstay in the treatment of Parkinson's disease. Since the late 1970's, a warning has appeared in the prescribing literature for levodopa regarding the risk of activating malignant melanoma. An evaluation was conducted of the case reports in which a casual relationship between levodopa and melanoma was suggested. CONCLUSIONS: There is an unlikely association between levodopa and induction or exacerbation of malignant melanoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available